Hu Zhang (Bushy Knotweed Root and Rhizome)

Chinese Herb Actions

Chinese Herb Dosage

• What is the typical dosage of Hu Zhang?

  Standard materia medica references give roughly 9–15 g decocted, with some sources extending the range to 15–30 g for more severe blood-stasis or damp-heat presentations; a 2023 pharmacological review of the herb likewise reports a typical clinical dosage window of about 10–30 g/day. Topically, Hu Zhang is prepared as a wash, powder, or ointment for burns, scalds, and sores — an external, not internal, dosing context.

  Source: cross-checked materia medica references (9–15 g core range); Ke et al. (2023), Pharmaceutical Biology, PMID 36620922, DOI 10.1080/13880209.2022.2158349 (10–30 g/day clinical range). Reference only — not a prescription.

Chinese Herb Contraindications & Cautions

• Are there cautions for Hu Zhang?

  Hu Zhang is contraindicated during pregnancy — as a blood-invigorating herb it is traditionally considered too moving/stasis-dispelling for use in pregnancy. It is also generally avoided, or used cautiously, in patients without genuine blood stasis or damp-heat (e.g., those with a weak Spleen/Stomach or loose stools), since its cold, draining nature can aggravate digestive weakness.

  • Pregnancy — contraindicated, per materia medica consensus.
  • Digestive sensitivity — being bitter and cold, it is used cautiously in patients with a weak digestion or loose stools; occasional gastrointestinal upset (nausea, loose stools) has been reported with internal use.

  Source: cross-checked materia medica references (pregnancy contraindication, digestive-caution pattern typical of bitter-cold herbs). Traditional-use framing; not medical advice.

Chinese Herb Toxicity & Overdose

• No significant toxicity is established for Hu Zhang at standard decoction doses, but the formal toxicology literature on the whole herb (as opposed to isolated constituents like resveratrol) is thin. A 2013 pharmacological review explicitly notes the absence of dedicated toxicity studies on Hu Zhang despite its long history of use, and a 2023 review flags a preclinical signal for nephrotoxicity as an area needing further investigation rather than an established finding.

  Note: because whole-herb toxicity data is limited, treat the “low toxicity at traditional doses” conclusion as consensus-by-long-use rather than a formally demonstrated safety profile; the nephrotoxicity signal noted in the 2023 review has not been confirmed as clinically significant at traditional dosing.

  Source: Zhang et al. (2013), Evidence-Based Complementary and Alternative Medicine, PMID 24194779, PMC 3806114, DOI 10.1155/2013/208349; Ke et al. (2023), Pharmaceutical Biology, PMID 36620922, PMC 9833411, DOI 10.1080/13880209.2022.2158349. Reference note, not a safety guarantee.

Herb-Drug Interactions

• The main documented concern is with anticoagulant/antiplatelet drugs (e.g., warfarin), based on resveratrol pharmacology rather than a clinical trial in Hu Zhang itself. An animal (rat) pharmacokinetic study found that resveratrol inhibits CYP2C9 and the BCRP transporter involved in warfarin clearance, increasing warfarin exposure and enhancing its anticoagulant effect — the authors flag a “hidden risk of bleeding” for warfarin-treated patients taking resveratrol. Because Hu Zhang is a rich dietary/herbal source of resveratrol, and is separately used traditionally as a blood-invigorating herb, practitioner awareness is reasonable for patients on anticoagulant or antiplatelet therapy. (Precautionary, extrapolated from resveratrol pharmacokinetics in an animal model — not a demonstrated clinical interaction for Hu Zhang itself; flagged for practitioner confirmation.)

  Source: Huang et al. (2020), Scientific Reports, PMID 32985569, PMC 7522226, DOI 10.1038/s41598-020-72694-0 (rat pharmacokinetic/pharmacodynamic study of resveratrol and warfarin).

Western / Biomedical Research

Chinese Herb Clinical Studies & Research

Provided as research context — a summary of published biomedical study, not a therapeutic or medical claim.

• Is there modern research on Hu Zhang (Polygonum cuspidatum)?

  Yes — Hu Zhang is one of the most heavily researched Chinese herbs in Western phytochemistry, mainly because it is a major natural source of resveratrol, emodin, and polydatin. Two comprehensive pharmacological reviews catalogue anti-inflammatory, antioxidant, hepatoprotective, cardioprotective, and antiviral activity for these constituents; a small human trial and an exploratory computational study add further, more specific evidence. Overall this is a large, mostly preclinical evidence base built around a small number of well-studied compounds rather than the whole traditional herb.

  • Comprehensive pharmacology reviews — a 2013 review catalogues anti-inflammatory (suppressing TNF-α, IL-1β, COX-2, NF-κB), cardioprotective, hepatoprotective, antimicrobial, neuroprotective, and antiviral (HIV-1, HBV) activity for Hu Zhang’s major constituents; a 2023 review adds antioxidant, anticancer (polydatin), and further cardioprotective and antiviral findings and lists a typical clinical dosage range of 10–30 g/day. Both are reviews of preclinical/laboratory data, not new clinical trials.
  • Human clinical (single small RCT) — a randomized, placebo-controlled trial in 20 male professional basketball players (200 mg/day Hu Zhang extract standardized to 40 mg trans-resveratrol, 6 weeks) found a significant reduction in plasma TNF-α and IL-6 versus placebo. Small, short, and in healthy athletes — treat as preliminary, single-study evidence, not a treatment claim.
  • Exploratory/computational (gouty arthritis) — a 2023 network-pharmacology and molecular-docking study modeled how Hu Zhang constituents (quercetin, luteolin, physovenine, beta-sitosterol) might inhibit IL-1β signaling relevant to gouty arthritis, echoing the herb’s traditional use for wind-damp painful joints. This is a computational/lab-bench study, not evidence of clinical effect.

  Note: the botanical name in the research literature varies — most pharmacology papers use “Polygonum cuspidatum,” while current botanical taxonomy favors Reynoutria japonica (also seen as Fallopia japonica, “Japanese knotweed”). These refer to the same plant behind our Latin, “Radix Et Rhizoma Polygoni Cuspidati”; the identity field is left unchanged pending owner confirmation.

  Sources: Zhang et al. (2013), Evidence-Based Complementary and Alternative Medicine, PMID 24194779, PMC 3806114, DOI 10.1155/2013/208349; Ke et al. (2023), Pharmaceutical Biology, PMID 36620922, PMC 9833411, DOI 10.1080/13880209.2022.2158349; Zahedi et al. (2013), International Journal of Preventive Medicine, PMID 23717757 (RCT, basketball players); Ge et al. (2023), Medicine (Baltimore), PMID 37478249, DOI 10.1097/MD.0000000000034396 (network pharmacology, gouty arthritis). Research context, not a therapeutic claim.

Chinese Herb Notes

• How does Hu Zhang compare to other blood-invigorating and damp-heat herbs, and what does it combine with?

  Hu Zhang is distinctive among blood-invigorating herbs for also clearing damp-heat and resolving toxicity in one herb — where herbs like Tao Ren or Hong Hua mainly move blood, and herbs like Yin Chen Hao mainly clear damp-heat jaundice, Hu Zhang is traditionally valued for doing both, plus its added phlegm-resolving, cough-stopping, and toxin-resolving actions.

  • For blood stasis (amenorrhea, dysmenorrhea, traumatic injury) — traditionally paired with other blood-invigorating herbs such as Dan Shen, Tao Ren, or Hong Hua.
  • For damp-heat jaundice — traditionally paired with Yin Chen Hao, the principal jaundice herb, and other damp-heat-clearing herbs such as Jin Qian Cao or Huang Bai.
  • For heat-toxin sores/carbuncles — traditionally paired with heat-toxin-resolving herbs such as Jin Yin Hua and Lian Qiao.

  Modern note (reference only): Hu Zhang (Polygonum cuspidatum, botanically also known as Reynoutria japonica or Fallopia japonica — the plant behind the common name “Japanese knotweed”) is one of the richest known natural sources of the stilbene resveratrol and the anthraquinone emodin, which is why it appears heavily in Western phytochemistry and supplement research (see Research, below). This is chemistry context, not a restatement of its traditional use.

  Source: cross-checked materia medica references for comparisons/pairings (general TCM combination patterns, not a specific classical formula citation); phytochemistry cross-reference from Zhang et al. (2013), PMID 24194779, and Ke et al. (2023), PMID 36620922. Traditional-use framing; not treatment advice.